Abstract
Branched-chain amino acids (BCAA) are used as a therapeutic nutritional supplement in patients with cirrhosis and hepatic encephalopathy (HE). During liver disease, the decreased capacity for urea synthesis and porto-systemic shunting reduce the hepatic clearance of ammonia and skeletal muscle may become the main alternative organ for ammonia detoxification. We here summarize current knowledge of muscle BCAA and ammonia metabolism with a focus on liver cirrhosis and HE. Plasma levels of BCAA are lower and muscle uptake of BCAA seems to be higher in patients with cirrhosis and hyperammonemia. BCAA metabolism may improve muscle net ammonia removal by supplying carbon skeletons for formation of alfa-ketoglutarate that combines with two ammonia molecules to become glutamine. An oral dose of BCAA enhances muscle ammonia metabolism but also transiently increases the arterial ammonia concentration, likely due to extramuscular metabolism of glutamine. We, therefore, speculate that the beneficial effect of long term intake of BCAA on HE demonstrated in clinical studies may be related to an improved muscle mass and nutritional status rather than to an ammonia lowering effect of BCAA themselves.
Similar content being viewed by others
References
Atherton PJ, Smith K, Etheridge T, Rankin D, Rennie MJ (2010) Distinct anabolic signalling responses to amino acids in C2C12 skeletal muscle cells. Amino Acids 38:1533–1539. doi:10.1007/s00726-009-0377-x
Bessman SP, Bradley JE (1955) Uptake of ammonia by muscle; its implications in ammoniagenic coma. N Engl J Med 253:1143–1147
Chatauret N, Desjardins P, Zwingmann C, Rose C, Rao KV, Butterworth RF (2006) Direct molecular and spectroscopic evidence for increased ammonia removal capacity of skeletal muscle in acute liver failure. J Hepatol 44:1083–1088
Clemmesen JO, Kondrup J, Ott P (2000) Splanchnic and leg exchange of amino acids and ammonia in acute liver failure. Gastroenterology 118:1131–1139
Dam G, Keiding S, Munk OL, Ott P, Buhl M, Vilstrup H, Bak LK, Waagepetersen HS, Schousboe A, Moller N, Sorensen M (2011) Branched-chain amino acids increase arterial ammonia in spite of enhanced intrinsic muscle ammonia metabolism in patients with cirrhosis and healthy subjects. Am J Physiol Gastrointest Liver Physiol 301:269–277
Ferrando AA, Williams BD, Stuart CA, Lane HW, Wolfe RR (1995) Oral branched-chain amino acids decrease whole-body proteolysis. J Parenter Enter Nutr 19:47–54
Fischer JE, Rosen HM, Ebeid AM, James JH, Keane JM, Soeters PB (1976) The effect of normalization of plasma amino acids on hepatic encephalopathy in man. Surgery 80:77–91
Ganda OP, Ruderman NB (1976) Muscle nitrogen metabolism in chronic hepatic insufficiency. Metabolism 25:427–435
Hayashi M, Ohnishi H, Kawade Y, Muto Y, Takahashi Y (1981) Augmented utilization of branched-chain amino acids by skeletal muscle in decompensated liver cirrhosis in special relation to ammonia detoxication. Gastroenterol Jpn 16:64–70
Holecek M (2010) Three targets of branched-chain amino acid supplementation in the treatment of liver disease. Nutrition 26:482–490
Horst D, Grace ND, Conn HO, Schiff E, Schenker S, Viteri A, Law D, Atterbury CE (1984) Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial. Hepatology 4:279–287
Iob V, Coon WW, Sloan M (1966) Altered clearance of free amino acids from plasma of patients with cirrhosis of the liver. J Surg Res 6:233–239
Leweling H, Breitkreutz R, Behne F, Staedt U, Striebel JP, Holm E (1996) Hyperammonemia-induced depletion of glutamate and branched-chain amino acids in muscle and plasma. J Hepatol 25:756–762
Marchesini G, Forlani G, Zoli M, Angiolini A, Scolari MP, Bianchi FB, Pisi E (1979) Insulin and glucagon levels in liver cirrhosis. Relationship with plasma amino acid imbalance of chronic hepatic encephalopathy. Dig Dis Sci 24:594–601
Marchesini G, Bianchi GP, Vilstrup H, Checchia GA, Patrono D, Zoli M (1987) Plasma clearances of branched-chain amino acids in control subjects and in patients with cirrhosis. J Hepatol 4:108–117
Marchesini G, Dioguardi FS, Bianchi GP, Zoli M, Bellati G, Roffi L, Martines D, Abbiati R (1990) Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group. J Hepatol 11:92–101
Marchesini G, Bianchi G, Merli M, Amodio P, Panella C, Loguercio C, Rossi Fanelli F, Abbiati R, Italian BCAA Study Group (2003) Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial. Gastroenterology 124:1792–1801
Morgan MY, Milsom JP, Sherlock S (1978) Plasma ratio of valine, leucine and isoleucine to phenylalanine and tyrosine in liver disease. Gut 19:1068–1073
Müting D, Wortman V (1956) Amino acid metabolism in liver diseases. Dtsch Med Wochenschr 81:1853–1856
Muto Y, Sato S, Watanabe A, Moriwaki H, Suzuki K, Kato A, Kato M, Nakamura T, Higuchi K, Nishiguchi S, Kumada H, Long-Term Survival Study Group (2005) Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol 3:705–713
Olde Damink SW, Jalan R, Redhead DN, Hayes PC, Deutz NE, Soeters PB (2002) Interorgan ammonia and amino acid metabolism in metabolically stable patients with cirrhosis and a TIPSS. Hepatology 36:1163–1171
Shinnick FL, Harper AE (1976) Branched-chain amino acid oxidation by isolated rat tissue preparations. Biochim Biophys Acta 437:477–486
Tischler ME, Desautels M, Goldberg AL (1982) Does leucine, leucyl-tRNA, or some metabolite of leucine regulate protein synthesis and degradation in skeletal and cardiac muscle? J Biol Chem 257:1613–1621
Tomiya T, Inoue Y, Yanase M, Arai M, Ikeda H, Tejima K, Nagashima K, Nishikawa T, Fujiwara K (2002) Leucine stimulates the secretion of hepatocyte growth factor by hepatic stellate cells. Biochem Biophys Res Commun 297:1108–1111
Windmueller HG, Spaeth AE (1974) Uptake and metabolism of plasma glutamine by the small intestine. J Biol Chem 249:5070–5079
Yamato M, Muto Y, Yoshida T, Kato M (1995) Clearance rate of plasma branched-chain amino acids correlates significantly with blood ammonia level in patients with liver cirrhosis. 3:91–96
Conflict of interest
The authors declare that they have no conflicts of interest
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dam, G., Ott, P., Aagaard, N.K. et al. Branched-chain amino acids and muscle ammonia detoxification in cirrhosis. Metab Brain Dis 28, 217–220 (2013). https://doi.org/10.1007/s11011-013-9377-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-013-9377-3